Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000592869 | SCV000701341 | likely pathogenic | not provided | 2016-07-18 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000648060 | SCV000769870 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2022-07-19 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asn109Ilefs*7) in the SGCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCA are known to be pathogenic (PMID: 9192266). This premature translational stop signal has been observed in individuals with SGCA-related conditions (Invitae). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 497103). |
Revvity Omics, |
RCV000648060 | SCV002020097 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2019-02-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000648060 | SCV003931658 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2D | 2023-02-08 | criteria provided, single submitter | clinical testing |